Drug

POLATUZUMAB VEDOTIN

Drug TypeAction TypeMechanism of ActionApprovedMax Trial PhaseMax GBM Phase
Antibody BINDING AGENT B-cell antigen receptor complex-associated protein beta chain binding agent no 4 0